Market Movers Today: Switch Inc (SWCH), Longfin Corp (LFIN), Cellectis SA (ADR) (CLLS), Adamas Pharmaceuticals Inc (ADMS), and More

Switch Inc (NYSE:SWCH) (The Motley Fool)
What happened: Shares of Switch (NYSE:SWCH) have gotten crushed today, down by 16% as of 12:20 p.m. EDT, after the data center specialist reported fourth-quarter earnings. Net losses were worse than expected. So what: Revenue in the fourth quarter came in at $99.3 million, which was just slightly shy of the $99.6 million in sales that analysts were modeling for.

Longfin Corp (NASDAQ:LFIN) (Yahoo Finance)
Longfin Corp. (LFIN): Shares are tumbling, down -31%. The blockchain tech firm revealed it is under SEC investigation for failing to disclose important information surrounding its recent IPO and several misstatements the company has made since then.

stocks, analysis, market, numbers, business, ticker, trade, money, price, investment, index, chart

crystal51/Shutterstock.com

Cellectis SA (ADR) (NASDAQ:CLLS) (Benzinga)
Cellectis S.A. shares climbed 10.6 percent to $34.00. Cellectis and Allogene Therapeutics intends to continue strategic cancer immunotherapy partnership which originally consisted of Pfizer and Cellectis.

Adamas Pharmaceuticals Inc (NASDAQ:ADMS) (Seeking Alpha)
Enrollment is underway in a Phase 3 clinical trial assessing Adamas Pharmaceuticals’ (ADMS +4.2%) GOCOVRI (amantadine) extended-release capsules in multiple sclerosis (MS) patients with walking impairment. The primary endpoint of the 540-subject study is timed 25 foot walk (T25FW) compared to placebo. Two once-daily doses (137 mg and 274 mg) will be evaluated. According to ClinicalTrials.gov, the estimated completion date is September 2019. The FDA approved GOCOVRI in August 2017 for dyskinesia (uncontrolled movements) in Parkinson’s disease patients receiving levodopa-based therapy.

Tesla Inc (NASDAQ:TSLA) (The Motley Fool)
What happened: Volatility in Tesla’s (NASDAQ:TSLA) stock price continued on Tuesday when shares rebounded, recovering somewhat from Monday’s decline. Shares climbed as much as 6.9% in morning trading, and were up 3.3% at the time of this writing. The stock’s rise came after Tesla’s update on quarterly vehicle deliveries and production on Tuesday morning. In what Tesla said was its “most productive quarter in Tesla history,” total vehicle production increased sharply and Model 3 deliveries soared. And in an important piece of news, Tesla reassured investors it won’t need to raise equity or issue debt this year.

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) (Benzinga)
Rigel Pharmaceuticals, Inc. shares dipped 17.2 percent to $2.9236. Rigel did not achieve primary endpoint for Phase 2 study of fostamatinib In IgA nephropathy.

CBS Corporation (NYSE:CBS) (CNBC)
CBS – CBS is considering an all-stock bid for Viacom that would value Viacom below its current market value, according to sources. The bid would propose that CBS CEO Leslie Moonves would stay at the combined company for at least two years. There is no word yet on the potential timing of any bid.

Amazon.com, Inc. (NASDAQ:AMZN) (Reuters)
WASHINGTON (Reuters) – Shares of Amazon.com Inc (AMZN.O) pared earlier gains on Tuesday after U.S. President Donald Trump repeated his unsubstantiated claim that deliveries for the world’s biggest online retailer cost the U.S. Postal Service money and threatened to raise rates. Citing an unnamed report, Trump told reporters at the White House the company is not paying the USPS a fair rate, costing U.S. taxpayers billions of dollars and forcing other retailers out of business.

Yogaworks Inc (NASDAQ:YOGA) (Benzinga)
YogaWorks, Inc. shares dipped 15.1 percent to $2.42. YogaWorks posted Q4 adjusted loss of $3.5 million on sales of $14.5 million. The company also issued a weak forecast for the current quarter.